通过对生物基和纳米技术方法的SWOT-AHP分析,评估先进废水处理采用的驱动因素和障碍
Nidal M Hussein1, Mohammed N Assaf2, Siti Khalijah Mahmad Rozi3
1Department of Civil Engineering, Faculty of Engineering, University of Petra, Amman, Jordan.
Journal of environmental management
|March 5, 2026
概括
基于生物和纳米技术的废水处理技术显示出前景,但面临采用障碍. 生物基技术是由重复利用潜力驱动的,而纳米技术在污染物清除方面表现出色,但两者都需要克服限制的策略.
科学领域:
- 环境科学 环境科学
- 化学工程是化学工程的重要组成部分.
- 材料科学 材料科学 材料科学
背景情况:
- 污水处理必须符合再利用标准,同时尽量减少能源和环境影响.
- 生物基和纳米技术解决方案提供了创新的方法,但面临着重大采用障碍.
- 了解这些障碍对于推动可持续的水资源管理至关重要.
研究的目的:
- 对生物基和纳米技术废水处理进行全面的SWOT (优点,弱点,机遇,威胁) 分析.
- 通过使用分析层次过程 (AHP) 与国际专家输入优先考虑采用驱动器和障碍.
- 制定可行的战略,以加快这些先进的处理技术的实施.
主要方法:
- 在技术,环境,社会经济,治理和健康方面进行SWOT分析.
- 将SWOT因素与分析层次流程 (AHP) 集成,以实现多标准优先级.
- 来自多样化的国际小组 (约旦,伊拉克,摩洛哥,突尼斯,西班牙,希腊,意大利,美国,马来西亚) 的专家提醒.
主要成果:
- 生物基技术受到融资和再利用潜力等机遇的青,但受到运营稳定性和生物固体接受度的限制.
- 基于纳米技术的技术在去除污染物方面表现出强大的技术性能,但受到成本,市场准备,安全和监管方面的担忧的阻碍.
- 优先考虑的因素和衍生措施为决策者提供了实际指导.
结论:
- 需要有针对性的战略来解决生物基和纳米技术废水处理的具体障碍.
- 克服运营稳定性,成本,市场准备和监管框架方面的限制是实现更广泛采用的关键.
- 本研究为推进全球可持续废水处理解决方案提供了一个结构化的框架.
相关概念视频
Environmental Applications of Microorganisms
1.3K
Microorganisms play a pivotal role in maintaining ecosystem balance by recycling essential elements such as carbon, nitrogen, and phosphorus, as well as supporting processes like bioremediation, wastewater treatment, and biofuel production.Microbes in Elemental CyclesIn the carbon cycle, microorganisms decompose organic matter, releasing carbon dioxide via aerobic respiration. This carbon dioxide is subsequently used by photosynthetic organisms to synthesize organic compounds, closing the...
1.3K
Bioavailability Enhancement: Drug Solubility Enhancement
389
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
389
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
305
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
305


